Further Information:
The Health Products Regulatory Authority has been notified of a shortage of the following products:
- Champix 1mg Tablet – EU/1/06/360/005
- Lignospan Special 20mg/12.5mg 2.2ml Solution for Injection – PA0196/013/001
- Lignospan Special 20mg/12.5mg 1.8ml Solution for Injection – PA0196/013/002
- Scandonest 3% w/v Solution for Injection – PA0196/015/001
- Teveten 600mg Film Coated Tablet – PA2010/017/002
- Xylonor 150mg/g + 1.5mg/g Oromucosal Spray – PA0196/014/001
- Xylonor 50mg/g + 1.5mg/g Gingival Gel – PA0196/014/002
The following shortages have been resolved and supply has resumed to the Irish market:
- Aprovel 75mg Film Coated Tablet – EU/1/97/046/017
- Aripiprazole Sandoz 5mg Tablet – EU/1/15/1029/001-014
- Aripiprazole Sandoz 10mg Tablet – EU/1/15/1029/015-028
- Aripiprazole Sandoz 15mg Tablet – EU/1/15/1029/029-042
- Foznol 1000mg Chewable Tablet – PA1575/002/004
- NeoMercazole 5mg Tablet – PA1142/002/001
- Rifadin 150mg Capsule – PA0540/066/001
Please see the shortages section of the HPRA website for further information.
The HPRA will be sending weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.